142 related articles for article (PubMed ID: 12042205)
1. Prolongation of QTc interval and antipsychotics.
Taylor DM
Am J Psychiatry; 2002 Jun; 159(6):1062; author reply 1064. PubMed ID: 12042205
[No Abstract] [Full Text] [Related]
2. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Taylor D
CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
[TBL] [Abstract][Full Text] [Related]
3. What can large simple trials do for psychiatry?
Stroup TS
Am J Psychiatry; 2011 Feb; 168(2):117-9. PubMed ID: 21297045
[No Abstract] [Full Text] [Related]
4. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
Finzel M; Fric M; Laux G
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic drugs and QT interval prolongation.
Zareba W; Lin DA
Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
[TBL] [Abstract][Full Text] [Related]
6. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of QTc interval and antipsychotics.
Su KP; Chang HC; Shen WW
Am J Psychiatry; 2002 Jun; 159(6):1062-3; author reply 1064. PubMed ID: 12042204
[No Abstract] [Full Text] [Related]
8. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
Kelly DL; Love RC
Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
[TBL] [Abstract][Full Text] [Related]
9. QTc prolongation: possible association with risperidone and/or haloperidol.
Nandagopal JJ; Craig JM; Lippmann S
Psychosomatics; 2003; 44(6):521. PubMed ID: 14597690
[No Abstract] [Full Text] [Related]
10. Single-dose ziprasidone associated with QT interval prolongation.
Witsil JC; Zell-Kanter M; Mycyk MB
Am J Emerg Med; 2012 Jun; 30(5):837.e1-2. PubMed ID: 21641143
[TBL] [Abstract][Full Text] [Related]
11. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
Minov C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T
J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445
[TBL] [Abstract][Full Text] [Related]
13. Drug safety evaluation of ziprasidone.
Citrome L
Expert Opin Drug Saf; 2011 May; 10(3):437-48. PubMed ID: 21332416
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of alcohol delirium can cause sudden cardiac death].
Pohjola-Sintonen S; Metsäniitty J
Duodecim; 1997; 113(13):1286-7. PubMed ID: 10622135
[No Abstract] [Full Text] [Related]
16. Methodological issues in a comparative study of ziprasidone and risperidone.
Gharabawi GM; Bossie CA; Mahmoud R; Canuso CM; Lasser RA; Turkoz I; Greenspan A
J Clin Psychiatry; 2006 Jan; 67(1):162-3; author reply 163-4. PubMed ID: 16426103
[No Abstract] [Full Text] [Related]
17. The safety of atypical antipsychotics: does QTc provide all the answers?
Nielsen J
Expert Opin Drug Saf; 2011 May; 10(3):341-4. PubMed ID: 21504386
[TBL] [Abstract][Full Text] [Related]
18. Prolongation of QTc interval and antipsychotics.
Agelink MW
Am J Psychiatry; 2002 Jun; 159(6):1063; author reply 1064. PubMed ID: 12042206
[No Abstract] [Full Text] [Related]
19. Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study.
Vieweg WV; Hasnain M
Am J Psychiatry; 2011 Jun; 168(6):650-1; author reply 651. PubMed ID: 21642483
[No Abstract] [Full Text] [Related]
20. Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia.
Mizuki Y; Takaki M
J Clin Psychopharmacol; 2015 Feb; 35(1):101-2. PubMed ID: 25502488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
